• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微乳和微乳基凝胶中的渗透促进剂:二甘醇单乙醚与油醇的比较

Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol.

作者信息

Pandey Sujata, Baki Gabriella

机构信息

Department of Pharmacy Practice, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, 3000 Arlington Ave, Toledo, OH 43614, USA.

出版信息

Gels. 2025 Jan 5;11(1):41. doi: 10.3390/gels11010041.

DOI:10.3390/gels11010041
PMID:39852012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11764590/
Abstract

Microemulsions have been commonly used with various permeation enhancers to improve permeability through the skin. The purpose of this study was to compare the release and permeation ability of two commonly used permeation enhancers-diethylene glycol monoethyl ether (DGME) and oleyl alcohol-by the changes in oil composition, the addition of a gelling agent, and water content using ibuprofen as a model drug. Four microemulsions were formulated, selection was based on ternary phase diagrams, and physicochemical properties were evaluated. The release and permeation of the microemulsion formulations were performed in vitro by Franz cell studies on a regenerated cellulose membrane and a Strat-M membrane, respectively, and the amount of ibuprofen permeated and released was analyzed by high-performance liquid chromatography (HPLC). All four microemulsions were compatible with the skin pH, and the average pH ranged from 4.9 to 5.6. The average droplet size of the microemulsions ranged from 119.8 to 153.3 nm. Drug release was significantly the highest from the gel-based microemulsions (59% and 64%, < 0.05). However, there was a fourfold difference in drug permeation from these gels-a significantly higher permeation from the microemulsion-gel containing oleic acid and oleyl alcohol compared to the DGME formulation. These results indicated that the microemulsion-gel with oleyl alcohol as the permeation enhancer could be a preferable formulation approach for the topical administration of ibuprofen. These results highlight the need for optimization of the microemulsion formulation to confirm the permeation-enhancing effects of chosen permeation enhancers despite being a well-known permeation enhancer.

摘要

微乳剂已普遍与各种渗透促进剂一起使用,以提高经皮渗透性。本研究的目的是通过改变油相组成、添加胶凝剂和含水量,以布洛芬为模型药物,比较两种常用渗透促进剂——二甘醇单乙醚(DGME)和油醇——的释放和渗透能力。制备了四种微乳剂,根据三元相图进行选择,并对其理化性质进行了评估。通过Franz扩散池分别在再生纤维素膜和Strat-M膜上进行微乳剂配方的体外释放和渗透实验,采用高效液相色谱(HPLC)分析布洛芬的渗透量和释放量。所有四种微乳剂均与皮肤pH值相容,平均pH值范围为4.9至5.6。微乳剂的平均液滴尺寸范围为119.8至153.3nm。基于凝胶的微乳剂的药物释放量显著最高(59%和64%,P<0.05)。然而,这些凝胶的药物渗透存在四倍差异——与DGME配方相比,含有油酸和油醇的微乳剂-凝胶的渗透显著更高。这些结果表明,以油醇作为渗透促进剂的微乳剂-凝胶可能是布洛芬局部给药的优选配方方法。这些结果突出了优化微乳剂配方的必要性,以确认所选渗透促进剂的渗透增强效果,尽管它是一种众所周知的渗透促进剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/ea0730dfc3cb/gels-11-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/9d008ba29695/gels-11-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/ce601c32ae2f/gels-11-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/ea0730dfc3cb/gels-11-00041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/9d008ba29695/gels-11-00041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/ce601c32ae2f/gels-11-00041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26bd/11764590/ea0730dfc3cb/gels-11-00041-g003.jpg

相似文献

1
Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol.微乳和微乳基凝胶中的渗透促进剂:二甘醇单乙醚与油醇的比较
Gels. 2025 Jan 5;11(1):41. doi: 10.3390/gels11010041.
2
Computer-based formulation design and optimization using Hansen solubility parameters to enhance the delivery of ibuprofen through the skin.利用 Hansen 溶解度参数通过计算机进行配方设计和优化以增强布洛芬经皮传递
Int J Pharm. 2019 Oct 5;569:118549. doi: 10.1016/j.ijpharm.2019.118549. Epub 2019 Aug 5.
3
Microemulsion-based hydrogel formulation of ibuprofen for topical delivery.用于局部给药的布洛芬微乳基水凝胶制剂。
Int J Pharm. 2006 Jun 6;315(1-2):52-8. doi: 10.1016/j.ijpharm.2006.02.015. Epub 2006 Apr 5.
4
Preparation and evaluation of aceclofenac topical microemulsion.醋氯芬酸外用微乳剂的制备与评价
Iran J Pharm Res. 2010 Winter;9(1):5-11.
5
Possibilities of the microemulsion use as indomethacin solubilizer and its effect on and drug permeation from dermal gels in comparison with transcutol.微乳在作为吲哚美辛增溶剂的可能性及其对经皮凝胶中 和 的药物渗透的影响,与 Transcutol 相比。
Drug Dev Ind Pharm. 2020 Sep;46(9):1468-1476. doi: 10.1080/03639045.2020.1802483. Epub 2020 Aug 7.
6
A Study of Microemulsion Systems for Transdermal Delivery of Risperidone Using Penetration Enhancers.透皮给予利培酮用微乳系统的研究——渗透促进剂的应用。
J Pharm Sci. 2023 Dec;112(12):3109-3119. doi: 10.1016/j.xphs.2023.07.007. Epub 2023 Jul 8.
7
A study of microemulsion systems for transdermal delivery of triptolide.雷公藤甲素经皮给药微乳体系的研究
J Control Release. 2004 Aug 27;98(3):427-36. doi: 10.1016/j.jconrel.2004.06.001.
8
Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).用于补骨脂油(补骨脂)局部给药的抗银屑病微乳凝胶制剂。
Methods Find Exp Clin Pharmacol. 2008 May;30(4):277-85. doi: 10.1358/mf.2008.30.4.1185802.
9
Formulation and evaluation of microemulsion-based hydrogel for topical delivery.用于局部给药的微乳液基水凝胶的制剂与评价
Int J Pharm Investig. 2012 Jul;2(3):140-9. doi: 10.4103/2230-973X.104397.
10
Jojoba oil-based microemulsion for transdermal drug delivery.用于透皮给药的荷荷巴油基微乳剂
Res Pharm Sci. 2021 Jun 30;16(4):326-340. doi: 10.4103/1735-5362.319572. eCollection 2021 Aug.

本文引用的文献

1
Skin Penetration and Permeation Properties of Transcutol in Complex Formulations.复杂制剂中环己醇的经皮渗透和渗透特性。
AAPS PharmSciTech. 2024 Sep 5;25(7):201. doi: 10.1208/s12249-024-02886-8.
2
Time-Dependent Differences in the Effects of Oleic Acid and Oleyl Alcohol on the Human Skin Barrier.油酸和油醇对人体皮肤屏障影响的时间依赖性差异。
Mol Pharm. 2023 Dec 4;20(12):6237-6245. doi: 10.1021/acs.molpharmaceut.3c00648. Epub 2023 Nov 11.
3
Release of Tretinoin Solubilized in Microemulsion from Carbopol and Xanthan Gel: In Vitro versus Ex Vivo Permeation Study.
维甲酸微乳剂从卡波姆和黄原胶凝胶中的释放:体外与离体渗透研究
Polymers (Basel). 2023 Jan 9;15(2):329. doi: 10.3390/polym15020329.
4
Microemulsions as transdermal drug delivery systems for nonsteroidal anti-inflammatory drugs (NSAIDs): a literature review.微乳作为非甾体抗炎药(NSAIDs)经皮给药系统:文献综述。
Drug Dev Ind Pharm. 2019 Dec;45(12):1849-1855. doi: 10.1080/03639045.2019.1680996. Epub 2019 Oct 22.
5
Computer-based formulation design and optimization using Hansen solubility parameters to enhance the delivery of ibuprofen through the skin.利用 Hansen 溶解度参数通过计算机进行配方设计和优化以增强布洛芬经皮传递
Int J Pharm. 2019 Oct 5;569:118549. doi: 10.1016/j.ijpharm.2019.118549. Epub 2019 Aug 5.
6
Skin Penetration and Permeation Properties of Transcutol®-Neat or Diluted Mixtures.经皮渗透和渗透性能的 Transcutol®-纯或稀释的混合物。
AAPS PharmSciTech. 2018 Nov;19(8):3512-3533. doi: 10.1208/s12249-018-1196-8. Epub 2018 Nov 12.
7
Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.用于治疗银屑病的糠酸莫米松局部纳米结构脂质载体水凝胶
Pharm Nanotechnol. 2018;6(2):133-143. doi: 10.2174/2211738506666180523112513.
8
Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications.基于聚山梨酯(吐温)的微乳液的进展:临床前药物递送、毒性及抗菌应用
Int J Pharm. 2017 Aug 30;529(1-2):134-160. doi: 10.1016/j.ijpharm.2017.06.059. Epub 2017 Jun 19.
9
Efficacy of nano- and microemulsion-based topical gels in delivery of ibuprofen: an in vivo study.基于纳米和微乳的局部用凝胶剂在布洛芬递送中的疗效:一项体内研究。
J Microencapsul. 2017 Mar;34(2):195-202. doi: 10.1080/02652048.2017.1316324. Epub 2017 May 8.
10
A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.使用Franz扩散池对布洛芬跨合成膜的跨膜扩散与渗透的比较研究。
Pharmaceutics. 2010 May 18;2(2):209-223. doi: 10.3390/pharmaceutics2020209.